Apnar Pharma Private Limited

Apnar Pharma Private Limited - pharma in Padra, Gujarat, India. FY 2026 financials & compliance.
CIN U73100GJ2014PTC081520 Incorporated 12 December 2014 ROC Ahmedabad HQ Padra, Gujarat, India
Active Private Limited Company pharma MSME · Medium
Revenue · FY 2025
₹14.22 Cr
▼ 48% YoY
Net loss · FY 2025
₹68.65 Lakh
Net margin -4.8%
EBITDA · FY 2025
₹4.24 Cr
EBITDA margin 29.8%
Authorised capital
₹7.6 Cr
Registered with MCA
Paid-up capital
₹7.55 Cr
Issued & subscribed
Open charges
₹50.35 Cr
Secured borrowings
Company age
12 yrs
Est. 2014
Employees · EPFO
128
Provident fund records

About Apnar Pharma Private Limited

Data last updated:

Apnar Pharma Private Limited is a private limited company based in Padra, Gujarat, India, a subsidiary of Apnar Pharma Lp. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 December 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U73100GJ2014PTC081520. Its GSTIN is 24AANCA0939J1ZK (Gujarat). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹7.6 Cr and a paid-up capital of ₹7.55 Cr. It was formerly known as Apnar Research Pharma Private Limited. It is led by directors including Umesh Patel and Dharmesh Bhikhabhai Patel.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Block No. 102 At & Po. Gavasad Padra Jambusar Road, Gujarat, India – 391430.

As per the financials filed for FY 2025, the company reported a revenue of ₹14.22 Cr, a decline of 48% compared to the previous year. For the same year it recorded a net loss of ₹68.65 Lakh (net margin -4.8%) and EBITDA of ₹4.24 Cr (EBITDA margin 29.8%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 21% over five years.

The company has about 128 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Apnar Pharma. As per MCA filings, the company has open charges of ₹50.35 Cr on record. Court records list 9 cases involving the company, including 9 filed against it. The company has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in March 2019. The company has 15 MSME Form 1 returns on record between 2018 and 2024, listing 4,417 overdue payments to 203 micro and small suppliers.

Apnar Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-24-0001741). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website apnarpharma.com.

Company details

CIN U73100GJ2014PTC081520
Registration Number 081520
Incorporation Date 12 December 2014
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Parent Company Apnar Pharma Lp
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-24-0001741

Recognitions & Rankings of Apnar Pharma

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-GJ-24-0001741

Contact details

Apnar Pharma Private Limited's registered office is in Padra, Gujarat. Its website is apnarpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Block No. 102 At & Po. Gavasad Padra Jambusar Road, Gujarat, India – 391430
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Apnar Pharma Private Limited, buy the company report.

Comprehensive company report
Apnar Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Apnar Pharma operates one associated brand: Apnar Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Produces high-quality pharmaceutical products including tablets, capsules, syrups, and injectables.apnarpharma.com

Business activity

The main business activity of Apnar Pharma is professional, scientific and technical. In detail, this covers scientific research and development.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM5Scientific research and development

To see the full business activity and turnover split of Apnar Pharma Private Limited, buy the company report.

Financials of Apnar Pharma Private Limited

FY 2025 filings available

Apnar Pharma Private Limited reported revenue of ₹14.22 Cr (down 48% YoY) for FY 2025.

Revenue · FY 2025
₹14.22 Cr ▼ 48%
Net loss · FY 2025
₹68.65 Lakh margin -4.8%
EBITDA · FY 2025
₹4.24 Cr margin 29.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 48%
3 years · compounded
▼ 2%
5 years · compounded
▲ 21%
EBITDA CAGR growth
1 year
▼ 41%
3 years · compounded
▲ 16%
5 years · compounded
▲ 22%

Revenue fell 48% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 21%. EBITDA fell 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.24 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹68.65 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin29.8%
Net Profit Margin-4.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Apnar Pharma Private Limited, buy the company report.

Board of directors of Apnar Pharma Private Limited

Apnar Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Umesh PatelDirector25 Feb 201511 Years 8 MonthsCurrent
Dharmesh Bhikhabhai PatelDirector24 Jan 201511 Years 9 MonthsCurrent
Swapnil Kantibhai PatelDirector12 Dec 201411 Years 11 MonthsCurrent

Auditor

Apnar Pharma Private Limited is audited by SHAH SANGHVI & ASSOCIATES for the financial year 2024.

Auditor firmFinancial yearFirm registration number
SHAH SANGHVI & ASSOCIATESFY 2024140107W

Shareholding

The shareholding of Apnar Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Apnar Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹50.35 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹30.49 Cr
Hdfc Bank Limited₹19.87 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
29 Jun 2022100595339Others₹7.5 CrOpen
09 Dec 2021100519438Others₹83.38 LakhOpen
24 Aug 2020100371015Others₹1.66 CrOpen
26 May 2020100347326Hdfc Bank Limited₹19.87 CrOpen
16 Dec 2017100145635Others₹11.49 CrOpen

To see the full charge records of Apnar Pharma Private Limited, buy the company report.

Total charge records: 6 View all charges

Deals & funding

Apnar Pharma Private Limited has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in March 2019.

Total deals
3
Rights issues
2
Secondary share transfer
1

Deals on record (3 of 3)

WhenDealAmountParties
Mar 2019Rights issue₹70 LakhInvestors: Apnar Pharma LP
Mar 2017Rights issue₹2.99 CrInvestors: Apnar Pharma LP
Feb 2017Secondary share transferUndisclosedBuyer: Apnar Pharma LP
Seller: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Apnar Pharma Private Limited has 15 MSME Form 1 returns on record between 2018 and 2024, listing 4,417 overdue payments to 203 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 203)

SupplierAmount dueDue sinceReported on
an individual supplier
Gayatri Industrial Gases
an individual supplier
Samvedna BMW Incinerator
an individual supplier

To see the full MSME payment records of Apnar Pharma Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Apnar Pharma Private Limited has a workforce of 128 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
128
Active EPFO establishments
1
Employee growth
178.3%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27128
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18

To see the full employee and EPFO history of Apnar Pharma Private Limited, buy the company report.

GST

Apnar Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
24AANCA0939J1ZKGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Apnar Pharma Private Limited, buy the company report.

Recent activity

Apnar Pharma Private Limited has 5 board changes on record since 2014: 3 appointments and 2 cessations. The latest: Kantibhai Bavabhai Patel ceased to be Director on 05 Sep 2024.

AGM
Apnar Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Apnar Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Kantibhai Bavabhai Patel ceased to be Director.
Ceased
Bhavesh Kishor Jagtap ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited of Rs. 19.87 Cr registered on 26 May 2020 with Charge ID 100347326 was modified on 25 Jul 2023.
Charges
A charge with Others amounted to Rs. 7.50 Cr with Charge ID 100595339 was registered on 29 Jun 2022.
Charges
A charge with Others of Rs. 11.49 Cr registered on 16 Dec 2017 with Charge ID 100145635 was modified on 25 Feb 2022.
Charges
A charge with Others amounted to Rs. 0.83 Cr with Charge ID 100519438 was registered on 09 Dec 2021.
Charges
A charge with Others amounted to Rs. 1.66 Cr with Charge ID 100371015 was registered on 24 Aug 2020.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 19.87 Cr with Charge ID 100347326 was registered on 26 May 2020.
Charges
A charge with Others amounted to Rs. 11.49 Cr with Charge ID 100145635 was registered on 16 Dec 2017.
Charges
A charge with Others amounted to Rs. 9.00 Cr with Charge ID 100145640 was registered on 11 Dec 2017.

4 earlier events are in the company report.

Frequently asked questions

Apnar Pharma is an active private limited company based in Padra, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 December 2014 (12+ years old) and is registered under CIN U73100GJ2014PTC081520.

Apnar Pharma has 3 current directors:

The latest financial statements of Apnar Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Apnar Pharma is 24AANCA0939J1ZK, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Apnar Pharma is U73100GJ2014PTC081520. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Apnar Pharma has 9 court cases on record: 9 filed against it.

Apnar Pharma was incorporated on 12 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Apnar Pharma has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in March 2019.

Kantibhai Bavabhai Patel ceased to be Director on 05 Sep 2024. Bhavesh Kishor Jagtap ceased to be Additional Director on 17 Aug 2023. Umesh Patel was appointed as Director on 25 Feb 2015. Apnar Pharma has 5 board changes on record in total.

Yes, Apnar Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-24-0001741).

Apnar Pharma has 15 MSME Form 1 returns on record between 2018 and 2024, listing 4,417 overdue payments to 203 micro and small suppliers. The latest return was filed on 02 May 2024.